论文部分内容阅读
1996年度已经过去,美国主要制药相关企业的业绩已经明朗。前10位排名,根据销售总收入,依次为强生公司、默克公司、百时美施贵宝公司、美国家用产品公司、辉瑞公司、雅培公司、礼莱公司、华纳·朗勃特公司、先灵葆雅公司、RPR公司。下面依次介绍其1996年业绩。 强生公司销售总收入为216.2亿美元(比上年增长14.7％),其中药品销售额为71.88亿美元(比上年增长14.6％)。在总销售收入中,药品占33.25％。药品销售在美国增长了25％,在国际市场增长了7％,国际药品销售额为
The year of 1996 has passed and the performance of the major pharmaceutical-related companies in the United States has become clear. The top 10 rankings, according to total sales revenue, were Johnson & Johnson, Merck, Bristol-Myers Squibb, U.S. Home Products, Pfizer, Abbott, Lilly, Warner-Lambert, Schering-Plough. RPR company. The following is a brief description of its 1996 performance. Johnson & Johnson’s total sales revenue was US$21.62 billion (a 14.7% increase over the previous year), with pharmaceutical sales of US$7.188 billion (a 14.6% increase over the previous year). In total sales revenue, drugs accounted for 33.25%. Drug sales increased by 25% in the United States, 7% in the international market, and international pharmaceutical sales were